What are the taboos for autumn health?
First, drugs and foods have both a health-care effect and certain side effects. A long-term service will affect the nutritional balance in the body. Especially for the elderly, not only the function of each organ has been reduced to varying degrees, but also needs to be comprehensively and systematically adjusted. In different seasons, there are different needs for health care drugs and food. Therefore, it is very necessary to adjust according to different situations.
Second, some people believe that the higher the price of the drug, the better the body can benefit. For example, ginseng, ginseng is high in price, and it is a holy medicine in tonics, so many people take it, but it should be noted that overuse of ginseng can lead to excessive excitement, irritability, high blood pressure and bleeding of the nostrils. Therefore, it is not the higher the price of the drug, the more it replenishes the body. This requires attention and attention.
Third, the idea that medicine is not as good as food supplement, and that medicine is light food is unscientific. For example, eating more leeks can treat high blood pressure; eating more radish can help stomach and digestion, suffocating wide chest, relieving phlegm and relieving cough; eating more yam can make up the spleen and stomach. Walnuts, peanuts, red dates, lentils, and glutinous rice that are eaten daily are also good tonics.
Fourth, "no disease, no medicine, no disease, no mess" is common sense of life. With the improvement of people's living standards, many people always want to eat supplements, "being awkward", but shake the foundation of the body, induce modern diseases, or increase the risk of getting sick. Experts suggest that before using drugs to supplement, you must first consult a doctor to achieve targeted, disease prevention and disease prevention, and do not pay for it, chaos to rectify the chaos.
How to maintain health in autumn?
The main climate of autumn is characterized by dryness, lack of moisture in the air, and the lack of water in the human body. The human body is prone to "stomachism" in a dry environment. Therefore, from the point of view of health, the autumn should be based on nourishing the body fluid, eat more nourishing yin, moistening dry food.
In the early autumn, health experts suggest that you can eat some foods or medicines that have spleen and heat, to eliminate the "sequel" of summer heat, and to regulate the function of the spleen and stomach, laying the foundation for the secondary, late autumn and even winter tonic. Like the fungus of Runfeishengjin, the yam that is not stagnation, the sesame that raises the intestines, the lily of the heart and the lungs, etc.
At present, many people, especially middle-aged and elderly people, have also turned their attention to health care. For healthy eating and strong bodybuilding, most people choose gun medicine to maintain their health. "The wine is the longest of a hundred drugs, the drink must be in moderation", from the book "Han Shu Food and Food". In ancient China, many long-lived people in the body will be beneficial to the body and food and food homologous materials into the wine, drink in moderation every day.
In addition, there is a dietary principle in autumn health that is more sour and less spicy. In the autumn, the lungs are ordered, and the spicy food helps the lungs. If the lungs are too busy, the lungs will cause respiratory problems such as cough and jaundice. The sour food enters the liver, and the liver gas can control the lungs, so that the human body is in a state of balance. Try to eat less or not eat ginger, garlic, pepper, spirits and other hot and dry products and fried, fatty things. Eat more sour foods, such as citrus, hawthorn and so on.
Ruxolitinib (also known as Rucotinib) is a kinase inhibitor indicated for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-thrombocythemia essential myelofibrosis. ruxolitinib (Jakavi), an oral JAK1 and JAK2 tyrosine kinase inhibitor, was approved in the EU in August 2012 for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis. Myelofibrosis after polycythemia vera and essential thrombocythemia.
Ruxolitinib Intermediates,Ruxolitinib Intermediate CAS 1153949-38-2,CAS 1153949-38-2 Ruxolitinib Intermediate,Ruxolitinib intermediates 3-Cyclopentylacrylonitrile
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com